Abstract:Purpose: We sought to investigate the risk of cataract development among patients with juvenile idiopathic arthritis (JIA)-associated uveitis treated with topical corticosteroids. Design: Retrospective cohort study. Participants: We included 75 patients with JIA-associated uveitis observed from July 1984 through August 2005 at a single academic center. Methods: Clinical data on these patients were collected by chart review and were analyzed. Main outcome measures: Incidence of new-onset cataract. Risk factors for cataract development were assessed with attention paid to the use of topical corticosteroids. Results: Over a median follow-up of 4 years, the incidence of new-onset cataract was 0.04/eye-year (EY; 95% confidence interval [CI], 0.02-0.09). Of the 60 eyes in 40 patients who received topical corticosteroid therapy, there was a dose-dependent increase in the rate of cataract development among eyes receiving topical corticosteroids. The incidence of cataract was 0.01/EY for eyes treated with <3 drops daily and 0.16/EY (P = 0.0006 for log-rank test) for eyes treated with >3 drops daily. Among eyes receiving <2 drops daily, the incidence of cataract was 0/EY (95% CI [1 sided], 0.03/EY). Presence of posterior synechiae, active uveitis, and use of topical corticosteroids at presentation were significantly associated with cataract development after controlling for confounding variables. Use of topical corticosteroids was associated with cataract formation independent of uveitis activity. Using longitudinal data analysis and controlling for duration of uveitis, presence and degree of active uveitis, and concomitant use of other forms of corticosteroids in a time-updated fashion, treatment with <3 drops daily of topical corticosteroid was associated with an 87% lower risk of cataract formation compared with eyes treated with >3 drops daily (relative risk, 0.13; 95% CI, 0.02-0.69; P = 0.02). Conclusions: In our cohort, topical corticosteroid use was associated with an increased risk of cataract formation independent of active uveitis or presence of posterior synechiae. However, chronic use of topical corticosteroids dosed at <3 drops daily seemed to be associated with a lower risk of cataract development relative to eyes receiving higher doses over follow-up in the setting of suppressed uveitis. Financial disclosure(s): Proprietary or commercial disclosure may be found after the references.

Sneutrino NLSP in the νCMSSM

Steroid induced glaucoma in the paediatric population

Steroid induced ocular complications in idiopathic nephrotic syndrome: a cross sectional single center study

Incidence of Steroid-Related Ocular Hypertension and Cataract Formation After Subtenon Triamcinolone in Non-Uveitic Pediatric Patients

Iatrogenic Cushing's Syndrome Due to Topical Ocular Glucocorticoid Treatment

Comparing glaucoma risk in children receiving low-dose and high-dose glucocorticoid treatment after cataract surgery

[Clinical Characteristics of Glucocorticoid-Induced Eye Adverse Reactions in Children with Primary Nephrotic Syndrome].

Risk of intraocular pressure elevation after topical steroids in children and adults: A systematic review

Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids

Brown McLean syndrome after congenital glaucoma surgery, unique case report and a literature review

Corticosteroid-induced intraocular pressure elevation in the pediatric patients: A protocol for systematic review

Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study

Non infectious ocular surface inflammation: Paediatric GVHD

Etiology and outcomes of childhood glaucoma at a tertiary referral center

Steroid Toxicity in Immune Thrombocytopenia – A Series of Unfortunate Events: A Case Report

Improvement in Echocardiographic and Diagnostic Biomarkers after Systemic Glucocorticoid Therapy in Infants with Pulmonary Hypertension

Prolonged hypotony maculopathy following uneventful strabismus surgery

Risk factors of pediatric steroid-induced ocular hypertension

High-Dose Steroid Treatment of Bacterial Keratitis

Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone

Subretinal Abscess Complicated by Post-infectious Retinal Vasculitis Following Strabismus Surgery